journal article·2020-10-21Open access

Immunodeficient Rabbit Models: History, Current Status and Future Perspectives

Jun Song, Brooke Pallas, Dongshan Yang, Jifeng Zhang, Yash Agarwal, Y. Eugene Chen, Moses Bility, Jie Xu

Applied Sciences· Volume 10· Issue 20

Abstract

Production of immunodeficient (ID) models in non-murine animal species had been extremely challenging until the advent of gene-editing tools: first zinc finger nuclease (ZFN), then transcription activator-like effector nuclease (TALEN), and most recently clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR)/Cas9. We and others used those gene-editing tools to develop ID rabbits carrying a loss of function mutation in essential immune genes, such as forkhead box protein N1 (FOXN1), recombination activating gene 1/2 (RAG1/2), and interleukin 2 receptor subunit gamma (IL2RG). Like their mouse counterparts, ID rabbits have profound defects in their immune system and are prone to bacterial and pneumocystis infections without prophylactic antibiotics. In addition to their use as preclinical models for primary immunodeficient diseases, ID rabbits are expected to contribute significantly to regenerative medicine and cancer research, where they serve as recipients for allo- and xeno-grafts, with notable advantages over mouse models, including a longer lifespan and a much larger body size. Here we provide a concise review of the history and current status of the development of ID rabbits, as well as future perspectives of this new member in the animal model family.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: CRISPR and Genetic Engineering · Virus-based gene therapy research · Viral Infectious Diseases and Gene Expression in Insects

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Advanced Models and Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, MI 48109, USA

Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109, USA

Department of Infectious Diseases and Microbiology, Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Public Health, Pittsburgh, PA 15261, USA

Funding

National Institutes of Health

References (100+)

Show source-provided references
1. Establishment in culture of pluripotential cells from mouse embryos
2. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells10.1073/pnas.78.12.7634 ↗
3. Transgenesis by means of blastocyst-derived embryonic stem cell lines10.1073/pnas.83.23.9065 ↗
4. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector
5. Use of rodents as models of human diseases10.4103/0975-7406.124301 ↗
6. Severe combined immunodeficiencies and related disorders10.1038/nrdp.2015.61 ↗
7. Blundell, M.P., and Kinnon, C. (2012). Animal Models of Human Primary Immunodeficiency Diseases. eLS.10.1002/9780470015902.a0001238.pub2 ↗
8. Humanized mice in translational biomedical research10.1038/nri2017 ↗
9. Strategies for Improving Animal Models for Regenerative Medicine10.1016/j.stem.2013.01.004 ↗
10. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease10.1126/science.288.5466.669 ↗
11. A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency10.1056/NEJM200301163480314 ↗
12. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients10.1172/JCI35798 ↗
13. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X110.1172/JCI35700 ↗
14. Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases10.1126/science.1172447 ↗
15. A TALE nuclease architecture for efficient genome editing10.1038/nbt.1755 ↗
16. Genetic engineering of human pluripotent cells using TALE nucleases10.1038/nbt.1927 ↗
17. A Simple Cipher Governs DNA Recognition by TAL Effectors10.1126/science.1178817 ↗
18. Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors10.1126/science.1178811 ↗
19. Multiplex Genome Engineering Using CRISPR/Cas Systems10.1126/science.1231143 ↗
20. RNA-Guided Human Genome Engineering via Cas910.1126/science.1232033 ↗
21. Genome editing in large animals: Current status and future prospects10.1093/nsr/nwz013 ↗
22. Equine severe combined immunodeficiency: A defect in V(D)J recombination and DNA-dependent protein kinase activity10.1073/pnas.92.25.11485 ↗
23. A kinase-negative mutation of DNA-PK(CS) in equine SCID results in defective coding and signal joint formation10.4049/jimmunol.158.8.3565 ↗
24. IL-2Rγ Gene Microdeletion Demonstrates That Canine X-Linked Severe Combined Immunodeficiency Is a Homologue of the Human Disease10.1006/geno.1994.1460 ↗
25. A single nucleotide insertion in the canine interleukin-2 receptor gamma chain results in X-linked severe combined immunodeficiency disease10.1016/0165-2427(94)05400-M ↗
26. SCID in Jack Russell Terriers: A New Animal Model of DNA-PKcs Deficiency10.4049/jimmunol.167.4.2142 ↗
27. DNA-PKcs mutations in dogs and horses: Allele frequency and association with neoplasia10.1016/S0378-1119(01)00880-0 ↗
28. Mashimo, T., Takizawa, A., Voigt, B., Yoshimi, K., Hiai, H., Kuramoto, T., and Serikawa, T. (2010). Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases. PLoS ONE, 5.10.1371/journal.pone.0008870 ↗
29. Generation and Characterization of Severe Combined Immunodeficiency Rats10.1016/j.celrep.2012.08.009 ↗
30. An Immune System-Modified Rat Model for Human Stem Cell Transplantation Research10.1016/j.stemcr.2018.06.004 ↗
31. A novel immunodeficient rat model supports human lung cancer xenografts10.1096/fj.201800102RR ↗
32. Generation of Immunodeficient Rats with Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models10.1097/TP.0000000000002251 ↗
33. Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs10.1016/j.stem.2012.04.021 ↗
34. Watanabe, M., Nakano, K., Matsunari, H., Matsuda, T., Maehara, M., Kanai, T., Kobayashi, M., Matsumura, Y., Sakai, R., and Kuramoto, M. (2013). Generation of Interleukin-2 Receptor Gamma Gene Knockout Pigs from Somatic Cells Genetically Modified by Zinc Finger Nuclease-Encoding mRNA. PLoS ONE, 8.10.1371/journal.pone.0076478 ↗
35. Production and rearing of germ-free X-SCID pigs10.1538/expanim.17-0095 ↗
36. Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency10.1016/j.vetimm.2016.06.011 ↗
37. Boettcher, A.N., Li, Y., Ahrens, A.P., Kiupel, M., Byrne, K.A., Loving, C.L., Cino-Ozuna, A.G., Wiarda, J.E., Adur, M., and Schultz, B. (2020). Novel Engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART−/−IL2RG−/Y SCID Pigs. Front. Immunol., 11.10.3389/fimmu.2020.00100 ↗
38. Partial loss of interleukin 2 receptor gamma function in pigs provides mechanistic insights for the study of human immunodeficiency syndrome10.18632/oncotarget.10812 ↗
39. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs10.1186/s12958-016-0206-5 ↗
40. Increased and prolonged human norovirus infection in RAG2/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency10.1038/srep25222 ↗
41. Generation of a Nonhuman Primate Model of Severe Combined Immunodeficiency Using Highly Efficient Genome Editing10.1016/j.stem.2016.06.003 ↗
42. Zschemisch, N.-H., Glage, S., Wedekind, D., Weinstein, E.J., Cui, X., Dorsch, M., and Hedrich, H. (2012). Zinc-finger nuclease mediated disruption of Rag1 in the LEW/Ztm rat. BMC Immunol., 13.10.1186/1471-2172-13-60 ↗
43. Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases
44. Ito, T., Sendai, Y., Yamazaki, S., Seki-Soma, M., Hirose, K., Watanabe, M., Fukawa, K., and Nakauchi, H. (2014). Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency. PLoS ONE, 9.10.1371/journal.pone.0113833 ↗
45. RAG1/2 Knockout Pigs with Severe Combined Immunodeficiency10.4049/jimmunol.1400915 ↗
46. Miao, J.-X., Ying, B., Li, R., Tollefson, A.E., Spencer, J.F., Wold, W.S.M., Song, S.-H., Kong, I., Toth, K., and Wang, Y. (2018). Characterization of an N-Terminal Non-Core Domain of RAG1 Gene Disrupted Syrian Hamster Model Generated by CRISPR Cas9. Viruses, 10.10.3390/v10050243 ↗
47. Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpox10.1038/srep11397 ↗
48. Sprague Dawley Rag2-Null Rats Created from Engineered Spermatogonial Stem Cells Are Immunodeficient and Permissive to Human Xenografts10.1158/1535-7163.MCT-18-0156 ↗
49. Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency10.1073/pnas.1406376111 ↗
50. Characterization of immunoglobulin heavy chain knockout rats10.1002/eji.201040939 ↗
51. Complete B Cell Deficiency Reduces Allograft Inflammation and Intragraft Macrophages a Rat Kidney Transplant Model10.1097/TP.0000000000002010 ↗
52. Generation of B Cell-Deficient Pigs by Highly Efficient CRISPR/Cas9-Mediated Gene Targeting10.1016/j.jgg.2015.05.002 ↗
53. Autosomal Recessive Severe Combined Immunodeficiency of Jack Russell Terriers10.1177/104063870201400302 ↗
54. Hypomorphic phenotype of Foxn1 gene-modified rats by CRISPR/Cas9 system10.1007/s11248-016-9941-9 ↗
55. Preliminary Findings of a Previously Unrecognized Porcine Primary Immunodeficiency Disorder10.1177/0300985812457790 ↗
56. Not All SCID Pigs Are Created Equally: Two Independent Mutations in the Artemis Gene Cause SCID in Pigs10.4049/jimmunol.1501132 ↗
57. B lymphocyte deficiency in IgH-transgenic rabbits10.1002/eji.200737191 ↗
58. Production of immunodeficient rabbits by multiplex embryo transfer and multiplex gene targeting10.1038/s41598-017-12201-0 ↗
59. Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas910.1038/s41598-020-66780-6 ↗
60. Generation of RAG 1- and 2-deficient rabbits by embryo microinjection of TALENs10.1038/cr.2013.85 ↗
61. Flisikowska, T., Thorey, I.S., Offner, S., Ros, F., Lifke, V., Zeitler, B., Rottmann, O., Vincent, A., Zhang, L., and Jenkins, S. (2011). Efficient Immunoglobulin Gene Disruption and Targeted Replacement in Rabbit Using Zinc Finger Nucleases. PLoS ONE, 6.10.1371/journal.pone.0021045 ↗
62. The wide utility of rabbits as models of human diseases10.1038/s12276-018-0094-1 ↗
63. Transgenic rabbits as therapeutic protein bioreactors and human disease models10.1016/S0163-7258(03)00069-X ↗
64. Transgenic Rabbit Models for Studying Human Cardiovascular Diseases
65. Rabbit Models for Studying Human Infectious Diseases
66. Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine10.1016/j.pharmthera.2014.09.009 ↗
67. Louis Pasteur and Rabies: A brief note10.1136/jnnp.73.1.82 ↗
68. Steps towards the discovery of Mycobacterium tuberculosis by Robert Koch, 188210.1111/1469-0691.12555 ↗
69. Defective Lipoprotein Receptors and Atherosclerosis10.1056/NEJM198308043090507 ↗
70. Fertilization of Rabbit Ova in vitro
71. Walter Heape, FRS: A pioneer in reproductive biology. Centenary of his embryo transfer experiments10.1530/jrf.0.0930173 ↗
72. Genome engineering technologies in rabbits
73. Rabbit models of human diseases for diagnostics and therapeutics development10.1016/j.dci.2018.10.003 ↗
74. An overview of the lagomorph immune system and its genetic diversity10.1007/s00251-015-0868-8 ↗
75. Molecular bases of genetic diversity and evolution of the immunoglobulin heavy chain variable region (IGHV) gene locus in leporids10.1007/s00251-011-0533-9 ↗
76. Discovery and analysis of the first endogenous lentivirus10.1073/pnas.0700471104 ↗
77. Parallel adaptation of rabbit populations to myxoma virus10.1126/science.aau7285 ↗
78. Rabbit haemorrhagic disease (RHD) and rabbit haemorrhagic disease virus (RHDV): A review10.1186/1297-9716-43-12 ↗
79. Song, J., Wang, G., Hoenerhoff, M.J., Ruan, J., Yang, D., Zhang, J., Yang, J., Lester, P.A., Sigler, R., and Bradley, M. (2018). Bacterial and Pneumocystis Infections in the Lungs of Gene-Knockout Rabbits with Severe Combined Immunodeficiency. Front. Immunol., 9.10.3389/fimmu.2018.00429 ↗
80. Recombinant Rabbit Leukemia Inhibitory Factor and Rabbit Embryonic Fibroblasts Support the Derivation and Maintenance of Rabbit Embryonic Stem Cells10.1089/cell.2012.0001 ↗
81. 31 full-term and live rabbit clones produced by somatic cell nuclear transfer10.1071/RDv18n2Ab31 ↗
82. Creating genetically modified pigs by using nuclear transfer10.1186/1477-7827-1-82 ↗
83. Production of α1,3-Galactosyltransferase-Knockout Cloned Pigs Expressing Human α1,2-Fucosylosyltransferase110.1095/biolreprod.102.014647 ↗
84. Transgenic pig expressing the enhanced green fluorescent protein produced by nuclear transfer using colchicine-treated fibroblasts as donor cells10.1002/mrd.10146 ↗
85. Human Factor IX Transgenic Sheep Produced by Transfer of Nuclei from Transfected Fetal Fibroblasts10.1126/science.278.5346.2130 ↗
86. Production of gene-targeted sheep by nuclear transfer from cultured somatic cells
87. Cloned Transgenic Calves Produced from Nonquiescent Fetal Fibroblasts10.1126/science.280.5367.1256 ↗
88. Generation of multi-gene knockout rabbits using the Cas9/gRNA system10.1186/2045-9769-3-12 ↗
89. Husbandry Efforts for Housing and Maintaining Immunodeficient Transgenic Rabbits
90. Rabbit sperm cryopreservation: A review10.1016/j.anireprosci.2008.08.015 ↗
91. Open-pulled straw vitrification differentiates cryotolerance of in vitro cultured rabbit embryos at the eight-cell stage10.1016/j.theriogenology.2010.10.018 ↗
92. A comparative encyclopedia of DNA elements in the mouse genome
93. Humanized mice for immune system investigation: Progress, promise and challenges10.1038/nri3311 ↗
94. Small Animal Models for Human Immunodeficiency Virus (HIV), Hepatitis B, and Tuberculosis: Proceedings of an NIAID Workshop10.2174/1570162X18666191223114019 ↗
95. Humanized immune system mouse models: Progress, challenges and opportunities10.1038/s41590-019-0416-z ↗
96. Samal, J., Kelly, S., Na-Shatal, A., Elhakiem, A., Das, A., Ding, M., Sanyal, A., Gupta, P., Melody, K., and Roland, B. (2018). Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model. JCI Insight, 3.10.1172/jci.insight.120430 ↗
97. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency10.1038/ncomms10548 ↗
98. Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges10.1016/j.cell.2015.08.068 ↗
99. Gene therapy and genome editing for primary immunodeficiency diseases10.1016/j.gendis.2019.07.007 ↗
100. Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice10.1038/nbt1326 ↗